< 1 minute read
Dec. 20, 2021
compound 59: a TRPM8 blocker
compound 59
TRPM8 blocker for ocular administration effective w/ ocular admin. in animal model cell-based screen. and opt. of thiazoles series Journal of Medicinal Chemistry Dompé Farmaceutici S.p.A
Other molecules you may be interested in
ONL1204
ONL1204 is ONL Therapeutics' small peptide inhibitor of the Fas receptor for IRD.